Persistent Organic Pollutants (Amendment) Regulations 2026
Tuesday, 17 November 2026
Contributions
Considered in Grand Committee
Moved by
Baroness Hayman of Ullock
That the Grand Committee do consider the Persistent Organic Pollutants (Amendment) Regulations 2026.
The Parliamentary Under-Secretary of State, Department for Environment, Food and Rural Affairs (Baroness Hayman of Ullock) (Lab)
My Lords, these regulations were laid before this House on 14 October 2026. This affirmative SI makes amendments to the existing persistent organic pollutants—POPs—regulation, as permitted by the use of powers available within Article 15 of the POPs regulation. It will prohibit the manufacturing, placing on the market and use of five recently adopted POPs. POPs are substances that have been agreed internationally by the United Nations Stockholm convention to be extremely dangerous to human health and the environment. So far, 37 POPs have been adopted for global prohibition under the convention. They account for a very small proportion of chemicals on the UK market. The identification and adoption of new POPs is based on thorough scientific analysis. Each new proposal undergoes years of evaluation and assessment by the convention, with engagement from Governments, industry, academia and other interested observers from around the world. Any proposed substances must be found to meet agreed criteria and be likely to lead to significant damage to human health or the environment, such that global action is warranted. The convention also considers the potential socioeconomic impacts resulting from a global ban. UK experts and stakeholders are very engaged in these processes. As a party to the convention, the UK has committed to implement the convention’s global prohibitions by adding them to the list of prohibited POPs in our POPs regulation. This instrument delivers this with respect to the five newest POPs that have been adopted for global elimination. Some of these substances have been used to perform important functions in products in key sectors, including within defence, aerospace and medical equipment. Because of this, certain exemptions for specific uses of each of the newly adopted POPs are also made available under the convention. These are determined following in-depth industry engagement and convention evaluation. They are all time-limited and many are sector-specific. This instrument introduces all the available time-limited exemptions that have been agreed by the convention for four of the five new POPs. The instrument does not include any of the available specific-use exemptions for one of the five new POPs because its use as a pesticide has already been completely phased out in the UK. The instrument also specifies thresholds for the lawful presence of each of these new POPs as unintentional trace contaminants. These thresholds are evidence-based and reflect in-depth engagement with industry and public consultation. In addition to the prohibitions for the five newer POPs, this instrument also amends prohibitions of two already-listed POPs. These amendments are primarily to tighten the existing thresholds for presence as unintentional trace contaminants, in response to scientific and technical progress, and to remove a reference to a standard that is no longer relevant. In effect, this instrument preserves and adds to our current regime for eliminating and managing harmful POPs in Great Britain and the United Kingdom. It also takes into account equivalent approaches being taken by other convention parties and key trading partners. It was the United Kingdom that led the proposal to list one of these new POPs under the Stockholm convention. This global leadership demonstrates the UK’s commitment to the protection of human and environmental health from the potential harms of POPs. We conducted a public consultation on the draft legislation to ensure that stakeholders could provide their views and evidence. This was held from March to May 2026. In September 2026, we published the summary of responses and a government response to confirm our intentions to deliver the proposals. From the outset, we have worked on the legislation with the relevant sectors of industry, including the UK chemicals sector and other major manufacturers. All costs, benefits and impacts have been assessed and published in an impact assessment accompanying this instrument. This impact assessment demonstrates why these measures are implemented through secondary legislation and the rationale for providing exemptions for specific uses and presence as unintentional trace contaminants. The specific use exemptions provide transitional arrangements for affected sectors, allowing continued use only in defined applications for a limited period, while businesses adapt supply chains and transition to safer alternatives. The Environment Agency is the enforcement authority for England, and Natural Resources Wales and the Scottish Environment Protection Agency are the enforcement authorities for Wales and Scotland, respectively. These authorities have been involved in the development of this instrument and have no concerns in relation to implementation or resources. The territorial application of this instrument is England, Wales and Scotland. We have engaged regularly with the devolved Governments on this legislation, and consent for this instrument has been received from Ministers in both the Welsh and Scottish Governments. Under the Windsor Framework, equivalent amendments to the EU POPs regulation will apply directly in Northern Ireland. We anticipate that the EU will make similar amendments to its EU POPs regulation where equivalent amendments are not already in force in the EU and Northern Ireland. These amendments will likely have similar intentions, outcomes and timescales in line with the EU’s equivalent obligations under the Stockholm convention. The Joint Committee on Statutory Instruments and the Secondary Legislation Scrutiny Committee have formally considered the instrument without comment. In conclusion, this measure is clear in its purpose to implement the Stockholm convention by adding the new POPs to the list of substances that are prohibited by law. These amendments will, in line with the purpose of the convention, help protect human health and the environment from these harmful substances. The instrument also amends the existing entries for two POPs, or groups of POPs, to align with scientific and technical progress. I hope noble Lords will support these measures and their objectives. I therefore commend the draft instrument to the Committee.
Viscount Stansgate (Lab)
My Lords, I will not detain the Committee for very long at all. This is a very detailed statutory instrument at nearly 100 pages, with detailed impact statements. My noble friend has ably explained the instrument, and I have one question: how quickly can a Government act when a persistent organic pollutant is identified as a new threat? The Minister has given some outline of the timetable leading up to this but, in principle, how quickly can we act?
Baroness Redfern (Con)
My Lords, regarding the amendment we are debating, my response is, first, to support it. It is important to protect the environment and control continued organic pollutants, as well as protecting the human health of the nation. From my past experience of working with my late husband, running our small agricultural and chemical enterprises, I know how important it is for small businesses’ responses to be heard as well as the input from very large organisations. I question whether adequate responses to this amendment were received from the small and medium-sized business sectors. It is interesting to note the number of responses His Majesty’s Government received.
Regarding the costs in particular, what further compliance costs will be placed on businesses prior to the official guidelines of 16 December 2026, if any?
Finally, regarding the statutory post-implementation review, which I note has not been scheduled until 2031, during this period will businesses be automatically updated as to any changes that may occur? Businesses need that assurance to help them plan for the future, particularly if further costs are to be applied.
Baroness Grender (LD)
My Lords, I thank the Minister for introducing these regulations, which we welcome from our Benches. These five chemicals share one grim quality: once they are out, they stay out, building up in wildlife and in the food chain, and, as my colleague, Dr Roz Savage MP, put it in the House of Commons, in most of our bodies. First, there is a slight sense of déjà vu about part of this instrument. In April 2025, the Government banned UV-328 and Dechlorane Plus, then revoked those bans when medical technology firms and others warned that they still needed them. As I understand it, it was to do with the chemicals still existing within some equipment of that nature. Can the Minister reassure the Committee that the exemptions have been got right this time so we are not back here in a year? Secondly, some of those exemptions end in 2030, but others run to 2041 or even 2044, and some simply last for the lifetime of the equipment—yet the regulations themselves contain no review clause at all. How will the Government make sure that “time-limited” really means what it says? Thirdly, the memorandum tells us that small and microbusinesses will be affected, but the consultation drew just 25 responses, mostly from trade associations and large firms. How did the department hear from small firms? I echo the question of the noble Baroness, Lady Redfern, about how, in partnership with small firms, similar chemicals can be eliminated from the chain. There is a very small point that caught my eye: that toys, children’s seats and cots made with recycled material may contain these flame retardants at 35 times the normal limit until May next year. I just wonder why we are waiting for that when it comes to children. In the long term, long-chain PFCAs are of course forever chemicals. In April, the Environmental Audit Committee, on which my colleague, Dr Savage, sits, found the Government’s PFAS plan long on monitoring and short on action. It asked Ministers to draw on the EU’s restriction within three months of its publication. Will the Minister commit to that or are we still waiting to see what Europe does? Finally, my noble friend Lord Teverson chaired this House’s inquiry into REACH during the Brexit negotiations. From these Benches, we warned then about the cost of drifting apart. I genuinely welcome the Government now saying that EU rules are the starting point for UK REACH, and, as I understood it from the opening remarks of the Minister, that Northern Ireland is aligning with that and that no aspect of the Windsor agreement will overly complicate that—in which case it is good that we are aligning as well. As far back as 2018, we were promised a chemicals strategy. I think everyone here is well aware that these chemicals have no respect whatever for any borders, whatever Brexit legacy we may or may not have. So, it is about time that our rules are aligned and keep up. By the way, just to reassure the Minister, I have fired off some questions, but I am extremely happy to be written to and not answered in her response, because I recognise that some of them are a little bit on the technical side.
Lord Roborough (Con)
My Lords, I also thank the Minister for bringing forward these regulations for scrutiny and for her excellent explanation of their purpose. To be classed as persistent organic pollutants, or POPs, substances must meet four criteria: a half-life of more than two months in water or six months in soil; building up in living organisms; demonstrating an ability to travel far from where they are released; and giving evidence of toxicity. The Stockholm convention restricts their use to protect our environment and our health, and we welcome the restrictions on these five POPs in this regulation. However, there is also the intention here to align more closely with the EU’s policies, including the substance definition itself. Can the Minister explain why we are adopting EU rules and definitions? We have no formal way to influence a future change to the definition, unless perhaps the Minister would like to provide insight into the terms of the Prime Minister’s upcoming dealings with the EU—obviously we do not expect that to happen. In addition, the eight-week consultation led to requests for new exemptions, but these have not been included. Can the Minister clarify that all exemptions are covered and give the Government’s rationale for not including those requested? Following the comments from the noble Baroness, Lady Grender, I understand that Dechlorane Plus and UV-328 were both banned in the UK in early 2025, before a rapid reversal one month later to avoid disruption in the NHS. Can the Minister confirm that the nature of the exemptions proposed in this instrument will lead to no disruption in the NHS or the defence sector, which she referenced in her opening comments? While we agree that provisions within this SI are required and the instrument has received favourable green ratings from the Regulatory Policy Committee, does the Minister appreciate the further cost to businesses? The impact assessment notes that there are costs such as familiarisation, compliance, reformulation, substitution and producer revenue costs. It estimates a negative business net present value, and the equivalent annual net direct cost to business is estimated to be £10.4 million. Is there any hope that the Government may be able to reduce these costs on businesses? I look forward to the Minister’s responses.
Baroness Hayman of Ullock (Lab)
My Lords, from the comments by my noble colleagues, I assume that everyone supports the instrument in front of us. It is clear that our approach has to balance regulatory compliance, environmental responsibility and the practical realities faced by industry across the UK. The noble Lord asked about much of those practical impacts. Our actions are guided not only by the domestic priorities but by our international commitments under the Stockholm convention and the evolving expectations of our global partners. The noble Lord, Lord Roborough, asked about the EU and the agreements that we are currently finishing negotiations on. This is an international commitment under the Stockholm convention; it is not tied to the negotiations with the EU. The legislation ensures that existing legal provisions for the prohibition and restriction of the manufacture, use and placing on the market of POPs will be extended to the newest POP substances that have been adopted for global elimination under the Stockholm convention. The reason for doing that is to continue to protect the current and future health of the population, wildlife and environment of both the United Kingdom and the rest of the world. We will also amend the legal provisions on the two existing POPs, as I mentioned, to adapt them to scientific and technical progress. The impact assessment, which has been referenced, clearly demonstrates that the changes are going to maintain a high level of protection for human health and the environment. At the same time, to come back to the noble Lord’s question about costs to industry, it is to avoid any unnecessary costs to industry, because that is really important. That is partly why we have the exemptions and the transition periods. The chemical sector is one of the United Kingdom’s most important manufacturing industries. Its products are essential to sectors right across the economy and to many aspects of our daily lives. We fully recognise the economic and strategic importance, but at the same time we have to recognise risks to human health and the environment if chemicals are not properly understood and managed. The instrument is designed to strike the right and appropriate balance here, preserving strong environmental and health protections while at the same time providing industry with the time and certainty that it is going to need to transition over to the safer alternative substances. I come to a few of the specific questions. My noble friend Lord Stansgate asked about new nominations and the timings for those. Clearly, if there are serious concerns about a chemical, we need to act as quickly as we possibly can. As a party to the Stockholm convention, we engage with its substance evaluation process via the POPs Review Committee and meetings of the Conference of the Parties, in addition to online correspondence. All relevant stakeholders have opportunities to put into the convention process through the calls for comments and information that we hold on the GOV.UK website. We currently have a live call for information on the three substances being considered for adoption by the committee; that is happening right now. We encourage stakeholders to submit information, as we need to be really robust. We need timely information to inform the international discussions taking place right now, so that we can move forward as quickly as we can under the circumstances. The noble Baroness, Lady Redfern, asked about consultation and the concerns of industry and business. A draft of the instrument was published as part of the statutory public consultation in spring this year. It sought feedback on our proposed approach to the prohibitions, on our intention to implement all the exemptions allowed for under the Stockholm convention and on equivalent amendments or proposals, including any potential impacts of divergence with the EU. It was shared widely with industry, including through other relevant departments and trade associations, so that we would hear from as many people as possible. We received 25 responses, primarily from large businesses and trade associations. Obviously, trade associations are often the bodies through which we hear from small and medium-sized businesses. We did as much as we could to engage as many businesses and industries as possible. On the assessment of the impacts on industry, as I mentioned, the impact assessment was published alongside the instrument. The evidence that we collected indicated that most businesses will not have to make any significant additional changes to their activity to comply with the new requirements. We also do not expect the amendments to have a significant distributional impact, nor will they —this is important for the noble Baroness’s question—disproportionately burden small businesses. In fact, the time-limited specific exemptions will help to ensure that transition, so that it does not put too much pressure on smaller businesses. On the post-implementation review that the noble Baroness referred to, a formal post-implementation review will commence by the end of 2031. This timing is intended to allow sufficient time for businesses to respond to the restrictions and for a number of the time-limited exemptions to have reached or approached their expiry date. That review will be supported by evidence provided through ongoing monitoring that will also take place. Additionally, as a party to the Stockholm convention, the UK is already required to undertake ongoing reporting and monitoring activities in line with our obligations under Articles 4 and 15 of the convention. This reporting and monitoring includes providing information on import and export and the use of specific exemptions. The information gathered through those processes will help inform the post-implementation review and could inform any future legislative changes that we might feel we want to bring in. The noble Baroness, Lady Grender, asked about the revocation of the UV-328 and Dechlorane Plus bans— the things that we have already been doing. They were previously prohibited under the POPs regulations in April 2025, including specific-use exemptions as allowed by the Stockholm convention. However, we received information that indicated previously unknown continuing needs for the use of these substances in certain applications, including medical and defence applications. I hope that helps to clarify that for the noble Baroness. That suggested that more time was needed to investigate impacts on supply chains and the transition to the alternatives. The Government therefore revoked the prohibitions on those two substances in May 2025 so that further evidence could be gathered. These issues were not confined to the UK, and other mitigations had to be implemented by other parties to the Stockholm convention. We committed at the time to reinstate the prohibitions as soon as possible, where sufficient evidence was gathered to provide greater certainty. To reassure the noble Baroness, we subsequently engaged with the relevant sectors and held a public consultation on the proposed draft legislation. We went through all the processes as we got the new information through. This instrument reinstates those prohibitions in line with the revised requirements of the Stockholm convention.
On exemptions, which were referred to, they were agreed at the convention’s Conference of the Parties, following extensive discussions and recommendations from the POPs Review Committee. As I said, this was to have time to find the alternative substances or take measures to reduce or stop the use of the substances. Parties can choose whether to implement the exemptions in their own domestic POPs legislation, taking into account the needs of their industry sectors. Again, I hope that is helpful. I have not responded to anything that was more technical, but I will make sure I get back to the noble Baroness and others in writing.
EU divergence was mentioned by noble Lords. Both the UK and the EU are parties to the Stockholm convention and are subject to the same obligations regarding prohibition of the harmful POPs adopted under the convention. In some instances, this instrument makes amendments that are already in force in the EU and Northern Ireland. For the more recently prohibited POPs, both we and the EU have prepared equivalent draft legislation in parallel to meet the same convention deadline of 16 December 2026. We do not anticipate any significant divergence issues between this instrument applying to Great Britain and the equivalent regulation in the EU and Northern Ireland. Consultation respondents highlighted that greater alignment with the EU and the convention would likely reduce business complexity and trade barriers and provide industry with greater certainty. Where minor technical differences exist, we do not expect these to create any substantive divergence implications between GB and Northern Ireland. Both we and the EU are working to meet the same international obligations—namely, and importantly, to prohibit these harmful POPs within the convention implementation deadline.
Finally, the noble Lord, Lord Roborough, asked about specific impacts on the NHS or defence. The impact assessment did not expect there to be a significant distributional impact, but also that the provision of the time-limited specific exemptions would help to ensure that industry—whether defence, the NHS or any other—has time to transition away from the use of these substances and would therefore mitigate against any adverse impacts. As I say, for questions that I have not responded to, including if they were particularly technical, I will do so in writing. I commend the draft regulations to the Committee.
Motion agreed.
← Previous
Administrative Court (Recording and Broadcasting) and Court of Appeal (Recording and Broadcasting) (Amendment) Order 2026
Next →
North Atlantic Salmon Conservation Organization (Immunities and Privileges) Order
Source: UK Parliament Hansard API. Debate ID: 5439336.